← Back to Screener
Senseonics Holdings, Inc. Common Stock (SENS)
Price$6.87
Favorite Metrics
Price vs S&P 500 (26W)-24.91%
Price vs S&P 500 (4W)-4.36%
Market Capitalization$287.13M
All Metrics
Book Value / Share (Quarterly)$1.48
P/TBV (Annual)3.74x
Revenue Growth (3Y)29.09%
Cash Flow / Share (Quarterly)$-1.46
Price vs S&P 500 (YTD)20.53%
Gross Margin (TTM)44.71%
Net Profit Margin (TTM)-196.03%
EPS (TTM)$-1.65
10-Day Avg Trading Volume0.30M
EPS Excl Extra (TTM)$-1.65
Revenue Growth (5Y)48.10%
EPS (Annual)$-1.66
ROI (Annual)-71.52%
Gross Margin (Annual)44.71%
Net Profit Margin (5Y Avg)-432.06%
Cash / Share (Quarterly)$2.28
Revenue Growth QoQ (YoY)71.82%
ROA (Last FY)-54.73%
Revenue Growth TTM (YoY)56.89%
EBITD / Share (TTM)$-1.60
ROE (5Y Avg)-58.95%
Operating Margin (TTM)-193.83%
Cash Flow / Share (Annual)$-1.46
P/B Ratio4.70x
P/B Ratio (Quarterly)3.69x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)8.01x
Net Interest Coverage (TTM)-90.78x
ROA (TTM)-54.89%
EPS Incl Extra (Annual)$-1.66
Current Ratio (Annual)4.83x
Quick Ratio (Quarterly)4.39x
3-Month Avg Trading Volume0.46M
52-Week Price Return-42.75%
EV / Free Cash Flow (Annual)1.96x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.46
P/S Ratio (Annual)8.14x
Asset Turnover (Annual)0.28x
52-Week High$15.74
Operating Margin (5Y Avg)-342.50%
EPS Excl Extra (Annual)$-1.66
CapEx CAGR (5Y)43.88%
Tangible BV CAGR (5Y)37.01%
26-Week Price Return-18.02%
Quick Ratio (Annual)4.39x
13-Week Price Return-5.50%
Total Debt / Equity (Annual)0.58x
Current Ratio (Quarterly)4.83x
Enterprise Value$282.487
Revenue / Share Growth (5Y)108.00%
Asset Turnover (TTM)0.28x
Book Value / Share Growth (5Y)94.53%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)3.50x
Pretax Margin (Annual)-196.03%
Cash / Share (Annual)$2.28
3-Month Return Std Dev73.25%
Gross Margin (5Y Avg)14.32%
Net Income / Employee (TTM)$-1
ROE (Last FY)-113.21%
Net Interest Coverage (Annual)-19.66x
EPS Basic Excl Extra (Annual)$-1.66
Receivables Turnover (TTM)3.83x
Total Debt / Equity (Quarterly)0.58x
EPS Incl Extra (TTM)$-1.65
Receivables Turnover (Annual)3.83x
ROI (TTM)-67.40%
P/S Ratio (TTM)8.14x
Pretax Margin (5Y Avg)-432.06%
Revenue / Share (Annual)$0.84
Tangible BV / Share (Annual)$1.46
Price vs S&P 500 (52W)-77.38%
Year-to-Date Return24.46%
5-Day Price Return1.78%
EPS Normalized (Annual)$-1.66
ROA (5Y Avg)-49.75%
Net Profit Margin (Annual)-196.03%
Month-to-Date Return3.15%
Cash Flow / Share (TTM)$-0.05
EBITD / Share (Annual)$-1.60
Operating Margin (Annual)-193.83%
LT Debt / Equity (Annual)0.58x
ROI (5Y Avg)-34.38%
LT Debt / Equity (Quarterly)0.58x
EPS Basic Excl Extra (TTM)$-1.65
P/TBV (Quarterly)3.74x
P/B Ratio (Annual)3.69x
Inventory Turnover (TTM)3.50x
Pretax Margin (TTM)-196.03%
Book Value / Share (Annual)$1.48
Price vs S&P 500 (13W)-7.88%
Beta1.07x
Revenue / Share (TTM)$0.78
ROE (TTM)-102.72%
52-Week Low$5.25
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.79
3.79
3.79
3.79
Industry Peers — Industrial Instruments(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SENSSenseonics Holdings, Inc. Common Stock | 8.14x | 48.10% | 44.71% | -193.83% | $6.87 |
DHRDanaher Corporation | 5.62x | 1.97% | 59.23% | 19.13% | $195.50 |
KEYSKeysight Technologies, Inc. | 10.13x | 4.95% | 61.86% | 15.96% | $338.69 |
AMEAmetek, Inc. | 7.33x | 10.27% | 36.38% | 25.65% | $236.82 |
ROPRoper Technologies, Inc. Common Stock | 4.69x | 14.46% | 69.24% | 28.29% | $359.87 |
MKSIMKS Inc. Common Stock | 4.80x | 11.03% | 46.74% | 13.18% | $286.32 |
FTVFortive Corporation | 3.65x | -2.14% | 60.96% | 16.35% | $61.61 |
CGNXCognex Corp | 9.31x | 4.16% | 66.92% | 16.35% | $55.48 |
STSensata Technologies Holding plc | 1.61x | 3.99% | 29.27% | 6.49% | $40.77 |
RALRalliant Corporation | 2.52x | — | 50.28% | -57.19% | $46.53 |
MLABMesa Laboratories Inc | 2.34x | 15.41% | 62.40% | 6.96% | $104.22 |
About
Senseonics Holdings is a medical technology company specializing in long-term implantable continuous glucose monitoring systems designed to help diabetes patients manage their condition. The company's integrated platform includes implantable sensors, smart transmitters, and a mobile application. The majority of its revenue is generated from international markets outside the United States.